Boston Scientific Corporation (BSX) Shareholder Argent Capital Management LLC Decreased Stake

May 3, 2018 - By Bridget Boland

Boston Scientific Corporation (NYSE:BSX) Corporate LogoDuring 2017 Q4 the big money sentiment increased to 1.34. That’s change of 0.30, from 2017Q3’s 1.04. 36 investors sold all, 158 reduced holdings as BSX ratio increased. 174 grew holdings while 86 funds took holdings. Funds hold 1.18 billion shares thus 2.38% less from 2017Q3’s 1.21 billion shares. Private Ocean Llc has 0% invested in Boston Scientific Corporation (NYSE:BSX) for 53 shs. Gotham Asset Management Limited Liability Com accumulated 503,669 shs or 0.18% of the stock. Dorsey And Whitney Tru Co Ltd Liability Corp holds 0.04% of its capital in Boston Scientific Corporation (NYSE:BSX) for 8,345 shs. Public Sector Pension Board invested in 73,426 shs or 0.01% of the stock. Shelton Capital accumulated 11,526 shs. State Of Alaska Department Of Revenue holds 0.1% or 177,300 shs. Prudential Public Limited Com reported 0% in Boston Scientific Corporation (NYSE:BSX). State Of New Jersey Common Pension Fund D holds 0.05% or 490,000 shs. Georgia-based Advisory Services Ntwk Lc has invested 0% in Boston Scientific Corporation (NYSE:BSX). Mutual Of America Mgmt Ltd Liability Company, a New York-based fund reported 217,122 shs. Nebraska-based Ameritas Inc has invested 0.03% in Boston Scientific Corporation (NYSE:BSX). Moreover, Pension Serv has 0.15% invested in Boston Scientific Corporation (NYSE:BSX) for 1.21M shs. Deltec Asset Mgmt Ltd accumulated 1.97% or 390,500 shs. Parametric Ltd Liability Com reported 2.88M shs stake. Kepos Cap LP invested in 0.32% or 144,509 shs.

BSX had 14 sales and 0 buys since December 29, 2017. This’s net activity of $7.38 million. Another trade for 16,286 shs valued at $439,722 was made by Pierce David A on Wednesday, February 21. $399,865 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Phalen Michael P. on Friday, December 29. On Wednesday, March 14 a trade for 42,803 shs valued at $1.21M was made by Ballinger Kevin J.. Another trade for 60,209 shs valued at $1.68M was sold by Brennan Daniel J.. 85,227 Boston Scientific Corporation (NYSE:BSX) shs with value of $2.26M were sold by Fitzgerald Joseph Michael.

According to 2017Q4 SEC form the Argent Capital Management Llc decreased its stake in Boston Scientific Corporation (BSX) by 32.57%. The company’s stock popped up 7.69% while Argent Capital Management Llc sold 647,753 shares. At the end of 2017Q4, the institutional investor held 1.34M shares of the medical and dental instruments company, valued at $37.50 million, down from 1.99M at the end of the previous reported quarter. Argent Capital Management Llc has risen its stake in Cisco Systems Inc. (NASDAQ:CSCO) and also increased its holding in Conocophillips (NYSE:COP) by 56,657 shares in the quarter, for a total of 396,852 shares.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

In total 18 analysts cover Boston Scientific Corp (NYSE:BSX). “Buy” rating has 16, “Sell” are 0, while 2 are “Hold”. (NYSE:BSX) has 89% bullish analysts. With $3600 highest and $27 lowest target, Boston Scientific Corp has $32.56 average target or 11.13% above the current ($29.3) price. 30 are the (NYSE:BSX)’s ratings reports on May 3, 2018 according to StockzIntelligence Inc. On Thursday, February 1 the firm earned “Buy” rating by RBC Capital Markets. On Friday, December 1 SunTrust maintained Boston Scientific Corporation (NYSE:BSX) with “Buy” rating. On Monday, March 19 the company was maintained by Morgan Stanley. On Wednesday, November 29 the stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Cowen & Co. On Wednesday, November 29 the firm earned “Buy” rating by Stifel Nicolaus. The stock rating was maintained by Stifel Nicolaus with “Buy” on Thursday, February 1. On Thursday, April 26 Leerink Swann maintained Boston Scientific Corporation (NYSE:BSX) with “Outperform” rating. On Friday, January 5 the stock of Boston Scientific Corporation (NYSE:BSX) earned “Top Pick” rating by RBC Capital Markets. On Wednesday, April 25 Stifel Nicolaus maintained the shares of BSX in report with “Buy” rating. On Sunday, November 5 the rating was maintained by RBC Capital Markets with “Buy”.

Boston Scientific Corporation (NYSE:BSX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: